Clinical studies recruiting near Lafayette

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

PSMA PET Combined With MRI for the Detection of PCa
Phase 3 · Southern Urology · Telix Pharmaceuticals (Innovations) Pty Limited · NCT07052214 A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease
Phase 3 · Gastroenterology Clinic of Acadiana · Janssen Research & Development, LLC · NCT07499232 Phase 2 Study to Evaluate Safety and Efficacy of Cretostimogene Grenadenorepvec in High-Risk NMIBC
Phase 2 · Southern Urology (Urology America) · CG Oncology, Inc. · NCT06567743 Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
Phase 2/Phase 3 · Kaiser Permanente-Rock Creek · NRG Oncology · NCT05174169 A Clinical Study of Intismeran Autogene (V940) and BCG in People With Bladder Cancer (V940-011/INTerpath-011)
Phase 2 · Southern Urology, LLC ( Site 0145) · Merck Sharp & Dohme LLC · NCT06833073 Comparing Impact of Treatment Before or After Surgery in Patients With Stage II-IIIB Resectable Non-small Cell Lung Canc
Phase 3 · Alliance for Clinical Trials in Oncology · NCT06632327 Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastati
Phase 3 · Kaiser Permanente-Rock Creek · Alliance for Clinical Trials in Oncology · NCT06931340 A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)
Phase 3 · Velocity Clinical Research · Eli Lilly and Company · NCT06672549 A Phase II Study to Investigate Lung Function With 2 Different Doses of Inhaled Glycopyrronium Taken With BFF Compared t
Phase 2 · Research Site · AstraZeneca · NCT07525375 ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathol
Phase 3 · Kaiser Permanente-Rock Creek · Alliance for Clinical Trials in Oncology · NCT06876714 Safety and Efficacy Study of Intravesical Instillation of TARA-002 in Adults With High-grade Non-muscle Invasive Bladder
Phase 2 · Southern Urology · Protara Therapeutics · NCT05951179 Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SL
Phase 3 · Good Samaritan Hospital - Cancer Centers of Colorado · National Cancer Institute (NCI) · NCT04269902 A Phase 3 Study of Revaccination in Subsequent Pregnancies With Bivalent RSV Vaccine and Duration of Protection of a Sin
Phase 3 · Velocity Clinical Research, Lafayette · Pfizer · NCT06866405 A Clinical Study to Evaluate the Safety and Efficacy of the FloStent in Men With Benign Prostatic Hyperplasia Symptoms
NA · Southern Urology · Rivermark Medical · NCT06849258 The THOR IDE Study
NA · Cardiovascular Institute of the South · Philips Clinical & Medical Affairs Global · NCT05916950 Study to Learn About Safety, Tolerability, and Immune Response of a Catch-up Pneumococcal Vaccine in Children and Adoles
Phase 3 · Velocity Clinical Research, Lafayette · Pfizer · NCT07660198 A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
Phase 3 · Akero Clinical Study Site · Akero Therapeutics, Inc · NCT06528314 Collection of Research Data and Samples From Patients Who Experience Immunotherapy Side Effects
Phase N/A · Alliance for Clinical Trials in Oncology · NCT04242095 A Surveillance Study of Susceptibility to Baloxavir Marboxil in Pediatric Participants With Influenza and Transmission o
Phase 3 · Velocity Clinical Research Lafayette · Hoffmann-La Roche · NCT06094010 Testing the Addition of Herceptin Hylecta or Phesgo to the Usual Chemotherapy for HER2 Positive Endometrial Serous Carci
Phase 3 · Franciscan Saint Elizabeth Health - Lafayette East · National Cancer Institute (NCI) · NCT05256225 A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
Phase 3 · 89bio Clinical Study Site · 89bio, Inc. · NCT06419374 An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerabilit
Phase 3 · Horizon Research Grp · Novartis Pharmaceuticals · NCT07517263 De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Eq
Phase 3 · NRG Oncology · NCT04852887 Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease o
Phase 3 · Clinical Trial Site · Alnylam Pharmaceuticals · NCT07181109 mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Neg
Phase 3 · Good Samaritan Hospital - Cancer Centers of Colorado · Alliance for Clinical Trials in Oncology · NCT05677490 Tissue Repair Gel in Venous Leg Ulcers (US)
Phase 3 · Clincial Research Site 01 · TR Therapeutics · NCT06707090 Galleri® in the Medicare Population.
NA · Ochsner Health Lafayette · GRAIL, Inc. · NCT05673018 Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With
Phase 3 · National Cancer Institute (NCI) · NCT07198074 MagDI U.S. Registry
Phase N/A · Ochsner Clinic Foundation · GT Metabolic Solutions, Inc. · NCT06928545 A Study to Evaluate the Efficacy of AXS-05 Compared to Bupropion in Preventing the Relapse of Depressive Symptoms
Phase 4 · Clinical Research Site · Axsome Therapeutics, Inc. · NCT06223880

Look up another city

Look up another condition